Good manufacturing practice in low‐ and middle‐income countries: Challenges and solutions for compliance
Abstract Approximately 2 billion people globally have limited access to essential medicines, particularly those living in low‐ and middle‐income countries (LMICs). In addition, there is a higher prevalence of substandard and counterfeit medicines in LMICs, which may cause antimicrobial resistance an...
Saved in:
Main Authors: | Pelden Chejor (Author), Thinley Dorji (Author), Ngawang Dema (Author), Andrew Stafford (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges of liver transplantation programs in low‐ and middle‐income countries: An experience from Sri Lanka
by: M. J. S. Jayarathna, et al.
Published: (2024) -
Promoting good health research practice in low- and middle-income countries
by: Yodi Mahendradhata, et al.
Published: (2016) -
Strengthening pandemic preparedness: Build the vaccine manufacturing capacity in low- and middle-income countries
by: Wu Zeng, et al.
Published: (2022) -
Mobile health solutions: An opportunity for rehabilitation in low- and middle income countries?
by: Bruno Bonnechère, et al.
Published: (2023) -
Regulatory flexibilities and access to COVID-19 vaccines during the pandemic in Bhutan
by: Dawa Tshering, et al.
Published: (2022)